Context Therapeutics (CNTX) Appoints Andy Pasternak as Board Chair

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. CDNS
3. SPY
4. META
5. JBLU
6. ANT
7. SSD
8. ARTV
9. AAPL
10. INTC

Go back to Context Therapeutics (CNTX) Appoints Andy Pasternak as Board Chair

Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors

January 13, 2025 7:30 AM EST

Mr. Pasternak brings decades of global pharmaceutical leadership experience

Transition further highlights transformation of the Board to lead Context into next phase of growth

PHILADELPHIA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (Context or the Company) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced the appointment of Andy Pasternak as Chairman of its Board of Directors, succeeding Richard Berman, who stepped down from the Board effective January 12, 2025. 

I am honored to become the next Chairman of the Board of... More